Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2026(Status and Outlook)
Chimeric Antigen Receptor (CAR) Cell Therapy is a type of immunotherapy that involves modifying a patient's own immune cells to recognize and attack cancer cells. The process begins by collecting the patient's T cells, a type of white blood cell, which are then genetically engineered to produce chimeric antigen receptors on their surface. These receptors enable the T cells to recognize specific proteins on the surface of cancer cells. Once the modified CAR T cells are infused back into the patient, they can target and destroy the cancer cells.
The global Chimeric Antigen Receptor Cell Therapy market size was estimated at USD 12500.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 22.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Chimeric Antigen Receptor Cell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Chimeric Antigen Receptor Cell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Chimeric Antigen Receptor Cell Therapy market.
Global Chimeric Antigen Receptor Cell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Market Segmentation (by Type)
MonOthersapy
Combination Therapy
Market Segmentation (by Application)
Acute Leukemia
Non-hodgkin's Lymphoma
Multiple Myeloma
Transplant Rejection
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chimeric Antigen Receptor Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Chimeric Antigen Receptor Cell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Chimeric Antigen Receptor Cell Therapy market size was estimated at USD 12500.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 22.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Chimeric Antigen Receptor Cell Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Chimeric Antigen Receptor Cell Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Chimeric Antigen Receptor Cell Therapy market.
Global Chimeric Antigen Receptor Cell Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Market Segmentation (by Type)
MonOthersapy
Combination Therapy
Market Segmentation (by Application)
Acute Leukemia
Non-hodgkin's Lymphoma
Multiple Myeloma
Transplant Rejection
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Chimeric Antigen Receptor Cell Therapy Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chimeric Antigen Receptor Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Chimeric Antigen Receptor Cell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Chimeric Antigen Receptor Cell Therapy
1.2 Key Market Segments
1.2.1 Chimeric Antigen Receptor Cell Therapy Segment by Type
1.2.2 Chimeric Antigen Receptor Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Chimeric Antigen Receptor Cell Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Chimeric Antigen Receptor Cell Therapy Product Life Cycle
3.3 Global Chimeric Antigen Receptor Cell Therapy Sales by Manufacturers (2020-2025)
3.4 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Chimeric Antigen Receptor Cell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Chimeric Antigen Receptor Cell Therapy Market Competitive Situation and Trends
3.8.1 Chimeric Antigen Receptor Cell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Chimeric Antigen Receptor Cell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Chimeric Antigen Receptor Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Chimeric Antigen Receptor Cell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Chimeric Antigen Receptor Cell Therapy Market
5.7 ESG Ratings of Leading Companies
6 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Type (2020-2025)
6.3 Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
6.4 Global Chimeric Antigen Receptor Cell Therapy Price by Type (2020-2025)
7 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chimeric Antigen Receptor Cell Therapy Market Sales by Application (2020-2025)
7.3 Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Chimeric Antigen Receptor Cell Therapy Sales Growth Rate by Application (2020-2025)
8 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SALES BY REGION
8.1 Global Chimeric Antigen Receptor Cell Therapy Sales by Region
8.1.1 Global Chimeric Antigen Receptor Cell Therapy Sales by Region
8.1.2 Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region
8.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.2.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.3 North America
8.3.1 North America Chimeric Antigen Receptor Cell Therapy Sales by Country
8.3.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Chimeric Antigen Receptor Cell Therapy Sales by Country
8.4.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales by Region
8.5.2 Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Chimeric Antigen Receptor Cell Therapy Sales by Country
8.6.2 South America Chimeric Antigen Receptor Cell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales by Region
8.7.2 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Chimeric Antigen Receptor Cell Therapy by Region(2020-2025)
9.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Chimeric Antigen Receptor Cell Therapy Production
9.4.1 North America Chimeric Antigen Receptor Cell Therapy Production Growth Rate (2020-2025)
9.4.2 North America Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Chimeric Antigen Receptor Cell Therapy Production
9.5.1 Europe Chimeric Antigen Receptor Cell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Chimeric Antigen Receptor Cell Therapy Production (2020-2025)
9.6.1 Japan Chimeric Antigen Receptor Cell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Chimeric Antigen Receptor Cell Therapy Production (2020-2025)
9.7.1 China Chimeric Antigen Receptor Cell Therapy Production Growth Rate (2020-2025)
9.7.2 China Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen Inc
10.1.1 Amgen Inc Basic Information
10.1.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.1.4 Amgen Inc Business Overview
10.1.5 Amgen Inc SWOT Analysis
10.1.6 Amgen Inc Recent Developments
10.2 Autolus Therapeutics Plc
10.2.1 Autolus Therapeutics Plc Basic Information
10.2.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Overview
10.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.2.4 Autolus Therapeutics Plc Business Overview
10.2.5 Autolus Therapeutics Plc SWOT Analysis
10.2.6 Autolus Therapeutics Plc Recent Developments
10.3 Beijing Immunochina Medical Science and Technology Co Ltd
10.3.1 Beijing Immunochina Medical Science and Technology Co Ltd Basic Information
10.3.2 Beijing Immunochina Medical Science and Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.3.3 Beijing Immunochina Medical Science and Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.3.4 Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
10.3.5 Beijing Immunochina Medical Science and Technology Co Ltd SWOT Analysis
10.3.6 Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
10.4 Bellicum Pharmaceuticals Inc
10.4.1 Bellicum Pharmaceuticals Inc Basic Information
10.4.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.4.4 Bellicum Pharmaceuticals Inc Business Overview
10.4.5 Bellicum Pharmaceuticals Inc Recent Developments
10.5 Bristol-Myers Squibb Co
10.5.1 Bristol-Myers Squibb Co Basic Information
10.5.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Overview
10.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.5.4 Bristol-Myers Squibb Co Business Overview
10.5.5 Bristol-Myers Squibb Co Recent Developments
10.6 bluebird bio Inc
10.6.1 bluebird bio Inc Basic Information
10.6.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.6.4 bluebird bio Inc Business Overview
10.6.5 bluebird bio Inc Recent Developments
10.7 CARsgen Therapeutics Ltd
10.7.1 CARsgen Therapeutics Ltd Basic Information
10.7.2 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.7.4 CARsgen Therapeutics Ltd Business Overview
10.7.5 CARsgen Therapeutics Ltd Recent Developments
10.8 Celgene Corp
10.8.1 Celgene Corp Basic Information
10.8.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Overview
10.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.8.4 Celgene Corp Business Overview
10.8.5 Celgene Corp Recent Developments
10.9 Cell Medica Ltd
10.9.1 Cell Medica Ltd Basic Information
10.9.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.9.4 Cell Medica Ltd Business Overview
10.9.5 Cell Medica Ltd Recent Developments
10.10 Cellular Biomedicine Group Inc
10.10.1 Cellular Biomedicine Group Inc Basic Information
10.10.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.10.4 Cellular Biomedicine Group Inc Business Overview
10.10.5 Cellular Biomedicine Group Inc Recent Developments
10.11 Celularity Inc
10.11.1 Celularity Inc Basic Information
10.11.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.11.4 Celularity Inc Business Overview
10.11.5 Celularity Inc Recent Developments
10.12 Celyad SA
10.12.1 Celyad SA Basic Information
10.12.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Overview
10.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.12.4 Celyad SA Business Overview
10.12.5 Celyad SA Recent Developments
10.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Basic Information
10.13.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.13.4 Daiichi Sankyo Co Ltd Business Overview
10.13.5 Daiichi Sankyo Co Ltd Recent Developments
10.14 Fosun Pharmaceutical AG
10.14.1 Fosun Pharmaceutical AG Basic Information
10.14.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Overview
10.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.14.4 Fosun Pharmaceutical AG Business Overview
10.14.5 Fosun Pharmaceutical AG Recent Developments
10.15 Gilead Sciences Inc
10.15.1 Gilead Sciences Inc Basic Information
10.15.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.15.4 Gilead Sciences Inc Business Overview
10.15.5 Gilead Sciences Inc Recent Developments
10.16 Guangzhou Anjie Biomedical Technology Co Ltd
10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Basic Information
10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
10.17 Hangzhou Converd Co Ltd
10.17.1 Hangzhou Converd Co Ltd Basic Information
10.17.2 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.17.4 Hangzhou Converd Co Ltd Business Overview
10.17.5 Hangzhou Converd Co Ltd Recent Developments
10.18 Hebei Senlang Biotechnology Inc Ltd
10.18.1 Hebei Senlang Biotechnology Inc Ltd Basic Information
10.18.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.18.4 Hebei Senlang Biotechnology Inc Ltd Business Overview
10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
10.19 HRAIN Biotechnology Co Ltd
10.19.1 HRAIN Biotechnology Co Ltd Basic Information
10.19.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.19.4 HRAIN Biotechnology Co Ltd Business Overview
10.19.5 HRAIN Biotechnology Co Ltd Recent Developments
10.20 Juno Therapeutics Inc
10.20.1 Juno Therapeutics Inc Basic Information
10.20.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.20.4 Juno Therapeutics Inc Business Overview
10.20.5 Juno Therapeutics Inc Recent Developments
10.21 Kite Pharma Inc
10.21.1 Kite Pharma Inc Basic Information
10.21.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.21.4 Kite Pharma Inc Business Overview
10.21.5 Kite Pharma Inc Recent Developments
10.22 Nanjing Legend Biotech Co Ltd
10.22.1 Nanjing Legend Biotech Co Ltd Basic Information
10.22.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.22.4 Nanjing Legend Biotech Co Ltd Business Overview
10.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
10.23 NantKwest Inc
10.23.1 NantKwest Inc Basic Information
10.23.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.23.4 NantKwest Inc Business Overview
10.23.5 NantKwest Inc Recent Developments
10.24 Nkarta Inc
10.24.1 Nkarta Inc Basic Information
10.24.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.24.4 Nkarta Inc Business Overview
10.24.5 Nkarta Inc Recent Developments
10.25 Novartis AG
10.25.1 Novartis AG Basic Information
10.25.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Overview
10.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.25.4 Novartis AG Business Overview
10.25.5 Novartis AG Recent Developments
10.26 Ono Pharmaceutical Co Ltd
10.26.1 Ono Pharmaceutical Co Ltd Basic Information
10.26.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.26.4 Ono Pharmaceutical Co Ltd Business Overview
10.26.5 Ono Pharmaceutical Co Ltd Recent Developments
10.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information
10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
10.28 Sorrento Therapeutics Inc
10.28.1 Sorrento Therapeutics Inc Basic Information
10.28.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.28.4 Sorrento Therapeutics Inc Business Overview
10.28.5 Sorrento Therapeutics Inc Recent Developments
10.29 Takara Bio Inc
10.29.1 Takara Bio Inc Basic Information
10.29.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.29.4 Takara Bio Inc Business Overview
10.29.5 Takara Bio Inc Recent Developments
11 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET FORECAST BY REGION
11.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast
11.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region
11.2.4 South America Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Chimeric Antigen Receptor Cell Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Chimeric Antigen Receptor Cell Therapy by Type (2026-2035)
12.1.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Chimeric Antigen Receptor Cell Therapy by Type (2026-2035)
12.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) Forecast by Application
12.2.2 Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Chimeric Antigen Receptor Cell Therapy
1.2 Key Market Segments
1.2.1 Chimeric Antigen Receptor Cell Therapy Segment by Type
1.2.2 Chimeric Antigen Receptor Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Chimeric Antigen Receptor Cell Therapy Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Chimeric Antigen Receptor Cell Therapy Product Life Cycle
3.3 Global Chimeric Antigen Receptor Cell Therapy Sales by Manufacturers (2020-2025)
3.4 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Chimeric Antigen Receptor Cell Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Chimeric Antigen Receptor Cell Therapy Market Competitive Situation and Trends
3.8.1 Chimeric Antigen Receptor Cell Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Chimeric Antigen Receptor Cell Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Chimeric Antigen Receptor Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Chimeric Antigen Receptor Cell Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Chimeric Antigen Receptor Cell Therapy Market
5.7 ESG Ratings of Leading Companies
6 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Type (2020-2025)
6.3 Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2020-2025)
6.4 Global Chimeric Antigen Receptor Cell Therapy Price by Type (2020-2025)
7 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chimeric Antigen Receptor Cell Therapy Market Sales by Application (2020-2025)
7.3 Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Chimeric Antigen Receptor Cell Therapy Sales Growth Rate by Application (2020-2025)
8 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SALES BY REGION
8.1 Global Chimeric Antigen Receptor Cell Therapy Sales by Region
8.1.1 Global Chimeric Antigen Receptor Cell Therapy Sales by Region
8.1.2 Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region
8.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.2.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.2.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.3 North America
8.3.1 North America Chimeric Antigen Receptor Cell Therapy Sales by Country
8.3.2 North America Chimeric Antigen Receptor Cell Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Chimeric Antigen Receptor Cell Therapy Sales by Country
8.4.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales by Region
8.5.2 Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Chimeric Antigen Receptor Cell Therapy Sales by Country
8.6.2 South America Chimeric Antigen Receptor Cell Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales by Region
8.7.2 Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Chimeric Antigen Receptor Cell Therapy by Region(2020-2025)
9.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Chimeric Antigen Receptor Cell Therapy Production
9.4.1 North America Chimeric Antigen Receptor Cell Therapy Production Growth Rate (2020-2025)
9.4.2 North America Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Chimeric Antigen Receptor Cell Therapy Production
9.5.1 Europe Chimeric Antigen Receptor Cell Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Chimeric Antigen Receptor Cell Therapy Production (2020-2025)
9.6.1 Japan Chimeric Antigen Receptor Cell Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Chimeric Antigen Receptor Cell Therapy Production (2020-2025)
9.7.1 China Chimeric Antigen Receptor Cell Therapy Production Growth Rate (2020-2025)
9.7.2 China Chimeric Antigen Receptor Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen Inc
10.1.1 Amgen Inc Basic Information
10.1.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.1.4 Amgen Inc Business Overview
10.1.5 Amgen Inc SWOT Analysis
10.1.6 Amgen Inc Recent Developments
10.2 Autolus Therapeutics Plc
10.2.1 Autolus Therapeutics Plc Basic Information
10.2.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Overview
10.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.2.4 Autolus Therapeutics Plc Business Overview
10.2.5 Autolus Therapeutics Plc SWOT Analysis
10.2.6 Autolus Therapeutics Plc Recent Developments
10.3 Beijing Immunochina Medical Science and Technology Co Ltd
10.3.1 Beijing Immunochina Medical Science and Technology Co Ltd Basic Information
10.3.2 Beijing Immunochina Medical Science and Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.3.3 Beijing Immunochina Medical Science and Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.3.4 Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
10.3.5 Beijing Immunochina Medical Science and Technology Co Ltd SWOT Analysis
10.3.6 Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
10.4 Bellicum Pharmaceuticals Inc
10.4.1 Bellicum Pharmaceuticals Inc Basic Information
10.4.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.4.4 Bellicum Pharmaceuticals Inc Business Overview
10.4.5 Bellicum Pharmaceuticals Inc Recent Developments
10.5 Bristol-Myers Squibb Co
10.5.1 Bristol-Myers Squibb Co Basic Information
10.5.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Overview
10.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.5.4 Bristol-Myers Squibb Co Business Overview
10.5.5 Bristol-Myers Squibb Co Recent Developments
10.6 bluebird bio Inc
10.6.1 bluebird bio Inc Basic Information
10.6.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.6.4 bluebird bio Inc Business Overview
10.6.5 bluebird bio Inc Recent Developments
10.7 CARsgen Therapeutics Ltd
10.7.1 CARsgen Therapeutics Ltd Basic Information
10.7.2 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.7.4 CARsgen Therapeutics Ltd Business Overview
10.7.5 CARsgen Therapeutics Ltd Recent Developments
10.8 Celgene Corp
10.8.1 Celgene Corp Basic Information
10.8.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Overview
10.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.8.4 Celgene Corp Business Overview
10.8.5 Celgene Corp Recent Developments
10.9 Cell Medica Ltd
10.9.1 Cell Medica Ltd Basic Information
10.9.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.9.4 Cell Medica Ltd Business Overview
10.9.5 Cell Medica Ltd Recent Developments
10.10 Cellular Biomedicine Group Inc
10.10.1 Cellular Biomedicine Group Inc Basic Information
10.10.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.10.4 Cellular Biomedicine Group Inc Business Overview
10.10.5 Cellular Biomedicine Group Inc Recent Developments
10.11 Celularity Inc
10.11.1 Celularity Inc Basic Information
10.11.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.11.4 Celularity Inc Business Overview
10.11.5 Celularity Inc Recent Developments
10.12 Celyad SA
10.12.1 Celyad SA Basic Information
10.12.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Overview
10.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.12.4 Celyad SA Business Overview
10.12.5 Celyad SA Recent Developments
10.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Basic Information
10.13.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.13.4 Daiichi Sankyo Co Ltd Business Overview
10.13.5 Daiichi Sankyo Co Ltd Recent Developments
10.14 Fosun Pharmaceutical AG
10.14.1 Fosun Pharmaceutical AG Basic Information
10.14.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Overview
10.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.14.4 Fosun Pharmaceutical AG Business Overview
10.14.5 Fosun Pharmaceutical AG Recent Developments
10.15 Gilead Sciences Inc
10.15.1 Gilead Sciences Inc Basic Information
10.15.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.15.4 Gilead Sciences Inc Business Overview
10.15.5 Gilead Sciences Inc Recent Developments
10.16 Guangzhou Anjie Biomedical Technology Co Ltd
10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Basic Information
10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
10.17 Hangzhou Converd Co Ltd
10.17.1 Hangzhou Converd Co Ltd Basic Information
10.17.2 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.17.4 Hangzhou Converd Co Ltd Business Overview
10.17.5 Hangzhou Converd Co Ltd Recent Developments
10.18 Hebei Senlang Biotechnology Inc Ltd
10.18.1 Hebei Senlang Biotechnology Inc Ltd Basic Information
10.18.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.18.4 Hebei Senlang Biotechnology Inc Ltd Business Overview
10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
10.19 HRAIN Biotechnology Co Ltd
10.19.1 HRAIN Biotechnology Co Ltd Basic Information
10.19.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.19.4 HRAIN Biotechnology Co Ltd Business Overview
10.19.5 HRAIN Biotechnology Co Ltd Recent Developments
10.20 Juno Therapeutics Inc
10.20.1 Juno Therapeutics Inc Basic Information
10.20.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.20.4 Juno Therapeutics Inc Business Overview
10.20.5 Juno Therapeutics Inc Recent Developments
10.21 Kite Pharma Inc
10.21.1 Kite Pharma Inc Basic Information
10.21.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.21.4 Kite Pharma Inc Business Overview
10.21.5 Kite Pharma Inc Recent Developments
10.22 Nanjing Legend Biotech Co Ltd
10.22.1 Nanjing Legend Biotech Co Ltd Basic Information
10.22.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.22.4 Nanjing Legend Biotech Co Ltd Business Overview
10.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
10.23 NantKwest Inc
10.23.1 NantKwest Inc Basic Information
10.23.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.23.4 NantKwest Inc Business Overview
10.23.5 NantKwest Inc Recent Developments
10.24 Nkarta Inc
10.24.1 Nkarta Inc Basic Information
10.24.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.24.4 Nkarta Inc Business Overview
10.24.5 Nkarta Inc Recent Developments
10.25 Novartis AG
10.25.1 Novartis AG Basic Information
10.25.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Overview
10.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.25.4 Novartis AG Business Overview
10.25.5 Novartis AG Recent Developments
10.26 Ono Pharmaceutical Co Ltd
10.26.1 Ono Pharmaceutical Co Ltd Basic Information
10.26.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.26.4 Ono Pharmaceutical Co Ltd Business Overview
10.26.5 Ono Pharmaceutical Co Ltd Recent Developments
10.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information
10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
10.28 Sorrento Therapeutics Inc
10.28.1 Sorrento Therapeutics Inc Basic Information
10.28.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.28.4 Sorrento Therapeutics Inc Business Overview
10.28.5 Sorrento Therapeutics Inc Recent Developments
10.29 Takara Bio Inc
10.29.1 Takara Bio Inc Basic Information
10.29.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Overview
10.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Market Performance
10.29.4 Takara Bio Inc Business Overview
10.29.5 Takara Bio Inc Recent Developments
11 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET FORECAST BY REGION
11.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast
11.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region
11.2.4 South America Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Chimeric Antigen Receptor Cell Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Chimeric Antigen Receptor Cell Therapy by Type (2026-2035)
12.1.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Chimeric Antigen Receptor Cell Therapy by Type (2026-2035)
12.2 Global Chimeric Antigen Receptor Cell Therapy Market Forecast by Application (2026-2035)
12.2.1 Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) Forecast by Application
12.2.2 Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (M USD)
Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application
Table 5. Chimeric Antigen Receptor Cell Therapy Market Size Comparison by Region (M USD)
Table 6. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Chimeric Antigen Receptor Cell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2025)
Table 11. Global Market Chimeric Antigen Receptor Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Chimeric Antigen Receptor Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Chimeric Antigen Receptor Cell Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Chimeric Antigen Receptor Cell Therapy Sales by Type (K Units)
Table 27. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (M USD)
Table 28. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type (2020-2025)
Table 32. Global Chimeric Antigen Receptor Cell Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) by Application
Table 34. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application
Table 35. Global Chimeric Antigen Receptor Cell Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application (2020-2025)
Table 39. Global Chimeric Antigen Receptor Cell Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Chimeric Antigen Receptor Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
Table 44. North America Chimeric Antigen Receptor Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Chimeric Antigen Receptor Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Chimeric Antigen Receptor Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Chimeric Antigen Receptor Cell Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Chimeric Antigen Receptor Cell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Amgen Inc Basic Information
Table 63. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 64. Amgen Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Amgen Inc Business Overview
Table 66. Amgen Inc SWOT Analysis
Table 67. Amgen Inc Recent Developments
Table 68. Autolus Therapeutics Plc Basic Information
Table 69. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 70. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Autolus Therapeutics Plc Business Overview
Table 72. Autolus Therapeutics Plc SWOT Analysis
Table 73. Autolus Therapeutics Plc Recent Developments
Table 74. Beijing Immunochina Medical Science and Technology Co Ltd Basic Information
Table 75. Beijing Immunochina Medical Science and Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 76. Beijing Immunochina Medical Science and Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
Table 78. Beijing Immunochina Medical Science and Technology Co Ltd SWOT Analysis
Table 79. Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
Table 80. Bellicum Pharmaceuticals Inc Basic Information
Table 81. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 82. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bellicum Pharmaceuticals Inc Business Overview
Table 84. Bellicum Pharmaceuticals Inc Recent Developments
Table 85. Bristol-Myers Squibb Co Basic Information
Table 86. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Overview
Table 87. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bristol-Myers Squibb Co Business Overview
Table 89. Bristol-Myers Squibb Co Recent Developments
Table 90. bluebird bio Inc Basic Information
Table 91. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 92. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. bluebird bio Inc Business Overview
Table 94. bluebird bio Inc Recent Developments
Table 95. CARsgen Therapeutics Ltd Basic Information
Table 96. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 97. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics Ltd Business Overview
Table 99. CARsgen Therapeutics Ltd Recent Developments
Table 100. Celgene Corp Basic Information
Table 101. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Overview
Table 102. Celgene Corp Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Celgene Corp Business Overview
Table 104. Celgene Corp Recent Developments
Table 105. Cell Medica Ltd Basic Information
Table 106. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 107. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cell Medica Ltd Business Overview
Table 109. Cell Medica Ltd Recent Developments
Table 110. Cellular Biomedicine Group Inc Basic Information
Table 111. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 112. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Cellular Biomedicine Group Inc Business Overview
Table 114. Cellular Biomedicine Group Inc Recent Developments
Table 115. Celularity Inc Basic Information
Table 116. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 117. Celularity Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Celularity Inc Business Overview
Table 119. Celularity Inc Recent Developments
Table 120. Celyad SA Basic Information
Table 121. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Overview
Table 122. Celyad SA Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Celyad SA Business Overview
Table 124. Celyad SA Recent Developments
Table 125. Daiichi Sankyo Co Ltd Basic Information
Table 126. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 127. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Daiichi Sankyo Co Ltd Business Overview
Table 129. Daiichi Sankyo Co Ltd Recent Developments
Table 130. Fosun Pharmaceutical AG Basic Information
Table 131. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Overview
Table 132. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Fosun Pharmaceutical AG Business Overview
Table 134. Fosun Pharmaceutical AG Recent Developments
Table 135. Gilead Sciences Inc Basic Information
Table 136. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 137. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Gilead Sciences Inc Business Overview
Table 139. Gilead Sciences Inc Recent Developments
Table 140. Guangzhou Anjie Biomedical Technology Co Ltd Basic Information
Table 141. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 142. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 144. Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
Table 145. Hangzhou Converd Co Ltd Basic Information
Table 146. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 147. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Hangzhou Converd Co Ltd Business Overview
Table 149. Hangzhou Converd Co Ltd Recent Developments
Table 150. Hebei Senlang Biotechnology Inc Ltd Basic Information
Table 151. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 152. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 154. Hebei Senlang Biotechnology Inc Ltd Recent Developments
Table 155. HRAIN Biotechnology Co Ltd Basic Information
Table 156. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 157. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. HRAIN Biotechnology Co Ltd Business Overview
Table 159. HRAIN Biotechnology Co Ltd Recent Developments
Table 160. Juno Therapeutics Inc Basic Information
Table 161. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 162. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Juno Therapeutics Inc Business Overview
Table 164. Juno Therapeutics Inc Recent Developments
Table 165. Kite Pharma Inc Basic Information
Table 166. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 167. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Kite Pharma Inc Business Overview
Table 169. Kite Pharma Inc Recent Developments
Table 170. Nanjing Legend Biotech Co Ltd Basic Information
Table 171. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 172. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Nanjing Legend Biotech Co Ltd Business Overview
Table 174. Nanjing Legend Biotech Co Ltd Recent Developments
Table 175. NantKwest Inc Basic Information
Table 176. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 177. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. NantKwest Inc Business Overview
Table 179. NantKwest Inc Recent Developments
Table 180. Nkarta Inc Basic Information
Table 181. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 182. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Nkarta Inc Business Overview
Table 184. Nkarta Inc Recent Developments
Table 185. Novartis AG Basic Information
Table 186. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Overview
Table 187. Novartis AG Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Novartis AG Business Overview
Table 189. Novartis AG Recent Developments
Table 190. Ono Pharmaceutical Co Ltd Basic Information
Table 191. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 192. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Ono Pharmaceutical Co Ltd Business Overview
Table 194. Ono Pharmaceutical Co Ltd Recent Developments
Table 195. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information
Table 196. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 197. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 199. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
Table 200. Sorrento Therapeutics Inc Basic Information
Table 201. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 202. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 203. Sorrento Therapeutics Inc Business Overview
Table 204. Sorrento Therapeutics Inc Recent Developments
Table 205. Takara Bio Inc Basic Information
Table 206. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 207. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 208. Takara Bio Inc Business Overview
Table 209. Takara Bio Inc Recent Developments
Table 210. Global Chimeric Antigen Receptor Cell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 211. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 212. North America Chimeric Antigen Receptor Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 213. North America Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 214. Europe Chimeric Antigen Receptor Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 215. Europe Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 216. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 217. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 218. South America Chimeric Antigen Receptor Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 219. South America Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 220. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 221. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 222. Global Chimeric Antigen Receptor Cell Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 223. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 224. Global Chimeric Antigen Receptor Cell Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 225. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 226. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (M USD)
Table 4. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application
Table 5. Chimeric Antigen Receptor Cell Therapy Market Size Comparison by Region (M USD)
Table 6. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Chimeric Antigen Receptor Cell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor Cell Therapy as of 2025)
Table 11. Global Market Chimeric Antigen Receptor Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Chimeric Antigen Receptor Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Chimeric Antigen Receptor Cell Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Chimeric Antigen Receptor Cell Therapy Sales by Type (K Units)
Table 27. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (M USD)
Table 28. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) by Type (2020-2025)
Table 29. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Type (2020-2025)
Table 30. Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) by Type (2020-2025)
Table 31. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type (2020-2025)
Table 32. Global Chimeric Antigen Receptor Cell Therapy Price (USD/Unit) by Type (2020-2025)
Table 33. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) by Application
Table 34. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application
Table 35. Global Chimeric Antigen Receptor Cell Therapy Sales by Application (2020-2025) & (K Units)
Table 36. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Application (2020-2025)
Table 37. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2020-2025) & (M USD)
Table 38. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application (2020-2025)
Table 39. Global Chimeric Antigen Receptor Cell Therapy Sales Growth Rate by Application (2020-2025)
Table 40. Global Chimeric Antigen Receptor Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 41. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region (2020-2025)
Table 42. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 43. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
Table 44. North America Chimeric Antigen Receptor Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 45. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Chimeric Antigen Receptor Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 50. South America Chimeric Antigen Receptor Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 51. South America Chimeric Antigen Receptor Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 54. Global Chimeric Antigen Receptor Cell Therapy Production (K Units) by Region(2020-2025)
Table 55. Global Chimeric Antigen Receptor Cell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Region (2020-2025)
Table 57. Global Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Chimeric Antigen Receptor Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Amgen Inc Basic Information
Table 63. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 64. Amgen Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Amgen Inc Business Overview
Table 66. Amgen Inc SWOT Analysis
Table 67. Amgen Inc Recent Developments
Table 68. Autolus Therapeutics Plc Basic Information
Table 69. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 70. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Autolus Therapeutics Plc Business Overview
Table 72. Autolus Therapeutics Plc SWOT Analysis
Table 73. Autolus Therapeutics Plc Recent Developments
Table 74. Beijing Immunochina Medical Science and Technology Co Ltd Basic Information
Table 75. Beijing Immunochina Medical Science and Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 76. Beijing Immunochina Medical Science and Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
Table 78. Beijing Immunochina Medical Science and Technology Co Ltd SWOT Analysis
Table 79. Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
Table 80. Bellicum Pharmaceuticals Inc Basic Information
Table 81. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 82. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bellicum Pharmaceuticals Inc Business Overview
Table 84. Bellicum Pharmaceuticals Inc Recent Developments
Table 85. Bristol-Myers Squibb Co Basic Information
Table 86. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Overview
Table 87. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bristol-Myers Squibb Co Business Overview
Table 89. Bristol-Myers Squibb Co Recent Developments
Table 90. bluebird bio Inc Basic Information
Table 91. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 92. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. bluebird bio Inc Business Overview
Table 94. bluebird bio Inc Recent Developments
Table 95. CARsgen Therapeutics Ltd Basic Information
Table 96. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 97. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. CARsgen Therapeutics Ltd Business Overview
Table 99. CARsgen Therapeutics Ltd Recent Developments
Table 100. Celgene Corp Basic Information
Table 101. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Overview
Table 102. Celgene Corp Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Celgene Corp Business Overview
Table 104. Celgene Corp Recent Developments
Table 105. Cell Medica Ltd Basic Information
Table 106. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 107. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Cell Medica Ltd Business Overview
Table 109. Cell Medica Ltd Recent Developments
Table 110. Cellular Biomedicine Group Inc Basic Information
Table 111. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 112. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Cellular Biomedicine Group Inc Business Overview
Table 114. Cellular Biomedicine Group Inc Recent Developments
Table 115. Celularity Inc Basic Information
Table 116. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 117. Celularity Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Celularity Inc Business Overview
Table 119. Celularity Inc Recent Developments
Table 120. Celyad SA Basic Information
Table 121. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Overview
Table 122. Celyad SA Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Celyad SA Business Overview
Table 124. Celyad SA Recent Developments
Table 125. Daiichi Sankyo Co Ltd Basic Information
Table 126. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 127. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Daiichi Sankyo Co Ltd Business Overview
Table 129. Daiichi Sankyo Co Ltd Recent Developments
Table 130. Fosun Pharmaceutical AG Basic Information
Table 131. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Overview
Table 132. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Fosun Pharmaceutical AG Business Overview
Table 134. Fosun Pharmaceutical AG Recent Developments
Table 135. Gilead Sciences Inc Basic Information
Table 136. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 137. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Gilead Sciences Inc Business Overview
Table 139. Gilead Sciences Inc Recent Developments
Table 140. Guangzhou Anjie Biomedical Technology Co Ltd Basic Information
Table 141. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 142. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 144. Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
Table 145. Hangzhou Converd Co Ltd Basic Information
Table 146. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 147. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Hangzhou Converd Co Ltd Business Overview
Table 149. Hangzhou Converd Co Ltd Recent Developments
Table 150. Hebei Senlang Biotechnology Inc Ltd Basic Information
Table 151. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 152. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 154. Hebei Senlang Biotechnology Inc Ltd Recent Developments
Table 155. HRAIN Biotechnology Co Ltd Basic Information
Table 156. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 157. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. HRAIN Biotechnology Co Ltd Business Overview
Table 159. HRAIN Biotechnology Co Ltd Recent Developments
Table 160. Juno Therapeutics Inc Basic Information
Table 161. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 162. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Juno Therapeutics Inc Business Overview
Table 164. Juno Therapeutics Inc Recent Developments
Table 165. Kite Pharma Inc Basic Information
Table 166. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 167. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Kite Pharma Inc Business Overview
Table 169. Kite Pharma Inc Recent Developments
Table 170. Nanjing Legend Biotech Co Ltd Basic Information
Table 171. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 172. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Nanjing Legend Biotech Co Ltd Business Overview
Table 174. Nanjing Legend Biotech Co Ltd Recent Developments
Table 175. NantKwest Inc Basic Information
Table 176. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 177. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. NantKwest Inc Business Overview
Table 179. NantKwest Inc Recent Developments
Table 180. Nkarta Inc Basic Information
Table 181. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 182. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. Nkarta Inc Business Overview
Table 184. Nkarta Inc Recent Developments
Table 185. Novartis AG Basic Information
Table 186. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Overview
Table 187. Novartis AG Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 188. Novartis AG Business Overview
Table 189. Novartis AG Recent Developments
Table 190. Ono Pharmaceutical Co Ltd Basic Information
Table 191. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 192. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 193. Ono Pharmaceutical Co Ltd Business Overview
Table 194. Ono Pharmaceutical Co Ltd Recent Developments
Table 195. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information
Table 196. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Overview
Table 197. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 198. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 199. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
Table 200. Sorrento Therapeutics Inc Basic Information
Table 201. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 202. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 203. Sorrento Therapeutics Inc Business Overview
Table 204. Sorrento Therapeutics Inc Recent Developments
Table 205. Takara Bio Inc Basic Information
Table 206. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Overview
Table 207. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 208. Takara Bio Inc Business Overview
Table 209. Takara Bio Inc Recent Developments
Table 210. Global Chimeric Antigen Receptor Cell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 211. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 212. North America Chimeric Antigen Receptor Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 213. North America Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 214. Europe Chimeric Antigen Receptor Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 215. Europe Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 216. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 217. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 218. South America Chimeric Antigen Receptor Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 219. South America Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 220. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Forecast by Country (2026-2035) & (Units)
Table 221. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 222. Global Chimeric Antigen Receptor Cell Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 223. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 224. Global Chimeric Antigen Receptor Cell Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 225. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 226. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Chimeric Antigen Receptor Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD), 2025-2035
Figure 5. Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Chimeric Antigen Receptor Cell Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Chimeric Antigen Receptor Cell Therapy Product Life Cycle
Figure 13. Chimeric Antigen Receptor Cell Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Manufacturers in 2025
Figure 15. Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Chimeric Antigen Receptor Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2025
Figure 18. Industry Chain Map of Chimeric Antigen Receptor Cell Therapy
Figure 19. Global Chimeric Antigen Receptor Cell Therapy Market PEST Analysis
Figure 20. Global Chimeric Antigen Receptor Cell Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type
Figure 27. Sales Market Share of Chimeric Antigen Receptor Cell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Chimeric Antigen Receptor Cell Therapy by Type in 2025
Figure 29. Market Share of Chimeric Antigen Receptor Cell Therapy by Type (2020-2025)
Figure 30. Market Share of Chimeric Antigen Receptor Cell Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application
Figure 33. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Application in 2025
Figure 35. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application (2020-2025)
Figure 36. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application in 2025
Figure 37. Global Chimeric Antigen Receptor Cell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
Figure 40. North America Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country in 2024
Figure 43. North America Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country in 2024
Figure 45. U.S. Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Chimeric Antigen Receptor Cell Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Chimeric Antigen Receptor Cell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Chimeric Antigen Receptor Cell Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Chimeric Antigen Receptor Cell Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country in 2024
Figure 53. Europe Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country in 2024
Figure 55. Germany Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region in 2024
Figure 68. China Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (K Units)
Figure 79. South America Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country in 2024
Figure 80. South America Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Chimeric Antigen Receptor Cell Therapy Market Size by Country in 2024
Figure 82. Brazil Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Chimeric Antigen Receptor Cell Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Chimeric Antigen Receptor Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Chimeric Antigen Receptor Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Chimeric Antigen Receptor Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Chimeric Antigen Receptor Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Chimeric Antigen Receptor Cell Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Chimeric Antigen Receptor Cell Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Chimeric Antigen Receptor Cell Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Chimeric Antigen Receptor Cell Therapy Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Chimeric Antigen Receptor Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD), 2025-2035
Figure 5. Global Chimeric Antigen Receptor Cell Therapy Market Size (M USD) (2020-2035)
Figure 6. Global Chimeric Antigen Receptor Cell Therapy Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Chimeric Antigen Receptor Cell Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Chimeric Antigen Receptor Cell Therapy Product Life Cycle
Figure 13. Chimeric Antigen Receptor Cell Therapy Sales Share by Manufacturers in 2025
Figure 14. Global Chimeric Antigen Receptor Cell Therapy Revenue Share by Manufacturers in 2025
Figure 15. Chimeric Antigen Receptor Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Chimeric Antigen Receptor Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Chimeric Antigen Receptor Cell Therapy Revenue in 2025
Figure 18. Industry Chain Map of Chimeric Antigen Receptor Cell Therapy
Figure 19. Global Chimeric Antigen Receptor Cell Therapy Market PEST Analysis
Figure 20. Global Chimeric Antigen Receptor Cell Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Chimeric Antigen Receptor Cell Therapy Market Share by Type
Figure 27. Sales Market Share of Chimeric Antigen Receptor Cell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Chimeric Antigen Receptor Cell Therapy by Type in 2025
Figure 29. Market Share of Chimeric Antigen Receptor Cell Therapy by Type (2020-2025)
Figure 30. Market Share of Chimeric Antigen Receptor Cell Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application
Figure 33. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Application in 2025
Figure 35. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application (2020-2025)
Figure 36. Global Chimeric Antigen Receptor Cell Therapy Market Share by Application in 2025
Figure 37. Global Chimeric Antigen Receptor Cell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Chimeric Antigen Receptor Cell Therapy Market Size by Region (2020-2025)
Figure 40. North America Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country in 2024
Figure 43. North America Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Chimeric Antigen Receptor Cell Therapy Market Size by Country in 2024
Figure 45. U.S. Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Chimeric Antigen Receptor Cell Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Chimeric Antigen Receptor Cell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Chimeric Antigen Receptor Cell Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Chimeric Antigen Receptor Cell Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country in 2024
Figure 53. Europe Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country in 2024
Figure 55. Germany Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Chimeric Antigen Receptor Cell Therapy Market Size by Region in 2024
Figure 68. China Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (K Units)
Figure 79. South America Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country in 2024
Figure 80. South America Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Chimeric Antigen Receptor Cell Therapy Market Size by Country in 2024
Figure 82. Brazil Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region in 2024
Figure 92. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Chimeric Antigen Receptor Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Chimeric Antigen Receptor Cell Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Chimeric Antigen Receptor Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Chimeric Antigen Receptor Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Chimeric Antigen Receptor Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Chimeric Antigen Receptor Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Chimeric Antigen Receptor Cell Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Chimeric Antigen Receptor Cell Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Chimeric Antigen Receptor Cell Therapy Market Share Forecast by Type (2026-2035)
Figure 111. Global Chimeric Antigen Receptor Cell Therapy Sales Forecast by Application (2026-2035)
Figure 112. Global Chimeric Antigen Receptor Cell Therapy Market Share Forecast by Application (2026-2035)
